Beaumont Financial Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,676
Closed -$273K – 389
2024
Q4
$273K Buy
1,676
+55
+3% +$9.84K 0.02% 304
2024
Q3
$317K Sell
1,621
-190
-10% -$35K 0.02% 268
2024
Q2
$314K Sell
1,811
-44
-2% -$7.32K 0.03% 268
2024
Q1
$314K Buy
1,855
+440
+31% +$82.4K 0.03% 270
2023
Q4
$279K Buy
1,415
+105
+8% +$18.6K 0.03% 277
2023
Q3
$228K Buy
+1,310
New +$238K 0.02% 289
2022
Q1
– Sell
-1,150
Closed -$281K – 392
2021
Q4
$281K Hold
1,150
– – 0.02% 285
2021
Q3
$223K Sell
1,150
-237
-17% -$47.8K 0.02% 328
2021
Q2
$259K Buy
+1,387
New +$241K 0.02% 316

Other funds holding ZTS

Beaumont Financial Advisors's ZTS Position: Q1 2025 in Review

Beaumont Financial Advisors sold out of Zoetis (ZTS) in Q1 2025, closing a stake of 1,676 shares — an estimated $273K sold.

Beaumont Financial Advisors first reported a position in ZTS in Q2 2021 and held it in 9 quarters. The position peaked at $317K in Q3 2024. 1,891 funds tracked by Wall St. Rank hold ZTS as of Q1 2025.

  • Beaumont Financial Advisors reported no remaining Zoetis position as of Q1 2025 after selling out during the quarter.
  • Beaumont Financial Advisors sold 1,676 Zoetis shares in Q1 2025, an estimated $273K.
  • Beaumont Financial Advisors first reported a position in Zoetis in Q2 2021 and held it in 9 quarters.
  • Beaumont Financial Advisors's Zoetis position peaked at $317K in Q3 2024.
  • 1,891 funds tracked by Wall St. Rank held Zoetis as of Q1 2025.

Based on Beaumont Financial Advisors's 13F filing for Q1 2025, filed 12 May 2025.